KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Acquisitions & Divestments (2016 - 2025)

Jazz Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 12 years, most recently at $180.0 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $180.0 million for Q4 2025, down 37.93% from a year ago — trailing twelve months through Dec 2025 was $1.4 billion (up 60.95% YoY), and the annual figure for FY2025 was $1.4 billion, up 60.95%.
  • Change in Acquisitions & Divestments for Q4 2025 was $180.0 million at Jazz Pharmaceuticals, down from $400.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for JAZZ hit a ceiling of $760.0 million in Q1 2021 and a floor of $20.0 million in Q3 2023.
  • Median Change in Acquisitions & Divestments over the past 5 years was $290.0 million (2024), compared with a mean of $279.2 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: soared 1675.0% in 2024 and later crashed 37.93% in 2025.
  • Jazz Pharmaceuticals' Change in Acquisitions & Divestments stood at $335.0 million in 2021, then crashed by 82.09% to $60.0 million in 2022, then surged by 316.67% to $250.0 million in 2023, then rose by 16.0% to $290.0 million in 2024, then crashed by 37.93% to $180.0 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $180.0 million (Q4 2025), $400.0 million (Q3 2025), and $470.0 million (Q2 2025) per Business Quant data.